Palantir has benefited from a boom in the adoption of GenAI technology as enterprises leverage the company’s expertise in managing and analyzing data to help train and run new AI apps using its platform. Analysts on average expect $3.75 billion in annual sales, according to data from LSEG. Palantir’s shares are up more than 60% this year, widely outperforming the benchmark S&P 500 Index, which is down more than 3%, as investors expect the company to benefit from AI deployment and government spending on defense-related tech even as global markets falter because of trade-related uncertainties.